United States· US:60505-0845_312454d0-6465-c4c7-991b-4c4e3bda33c2
Olopatadine Hydrochloride
A olopatadine product containing olopatadine hydrochloride, registered in United States by Apotex Corp.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Olopatadine is registered in 2 of 19 countries.
Countries holding a registration under ATC R01AC08 (olopatadine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Olopatadine · ATC R01AC08
2 / 19 countries
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLOPATADINE HYDROCHLORIDE
- Manufacturer
- Apotex Corp.
- Country
- United States (US)
- ATC code
- R01AC08
- ATC class
- Olopatadine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 20, 2026
Packs & prices · 2
- ndc1160505084551 BOTTLE in 1 CARTON (60505-0845-5) / 240 SPRAY, METERED in 1 BOTTLE
- ndc1160505-0845-5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
454 interactions on record for olopatadine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olopatadine · interactions on record
454 records
- 2 severe
- 310 moderate
- 142 info
Most severe, free to view
- Sodium oxybateN01AX11severe
- DicycloverineA03AA07moderate
- AtropineA03BA01moderate
- HyoscyamineA03BA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olopatadine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHayeeze 1mg/ml eye dropsDrugsrus Ltd
- CanadaAPO-OLOPATADINEAPOTEX INC
- SpainAPADIN 1 MG/ML COLIRIO EN SOLUCIONTiedra Farmaceutica S.L.
- SwedenOlopatadin Evolan 1 mg/ml Ögondroppar, lösningEvolan Pharma AB
- CzechiaOLOPATADINE OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- GermanyAlltrevoActrevo Gmbh
- PolandOftahistAdamed Pharma S.A.
- BelgiumOpatanol 1 mg/mlNovartis Europharm
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Olopatadin Micro Labs, Olopatadin Unimed Pharma
- Bulgaria · Оловижън, Олопатадин Унимед Фарма
- Cyprus · Alopatan, Olopatadine Rafarm
- Czechia · Olopatadine Unimed Pharma, Olopatidine Olikla
- Germany · Alltrevo, Olopatadin Actrevo
- Denmark · Olopatadin Brown & Burk, Olopatadin Juta
- Estonia · Olopatadine Unimed Pharma
- Spain · Apadin, Olopatadina Abamed
- United Kingdom (Northern Ireland) · Olopatadine Blumont Pharma, Olopatadine Brown & Burk Uk
- Greece · Alopatan, Olopatadine Rafarm
- Croatia · Olopatadin
- Hungary · Olopatadine Unimed Pharma
- Ireland · Olopatadine Brown & Burk
- Iceland · Opatanol
- Italy · Calmira®, Olonet
- Liechtenstein · Opatanol
- Lithuania · Olopatadine Unimed Pharma
- Latvia · Olopatadine Unimed Pharma
- Malta · Olopatadine Unimed Pharma
- Netherlands · Olopatadine Brown & Burk, Optamont
- Norway · Olopatadine Sandoz, Opatanol
- Poland · Oftahist, Olodon Free
- Portugal · Olopatadina Stallpharma
- Romania · Olopatadina Brown & Burk, Olopatadină Rompharm
- Sweden · Olopatadin Evolan, Olopatadin Orifarm
- Slovenia · Olopatadin Unimed Pharma
- Slovakia · Olopatadine Olikla, Olopatadine Unimed Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1ff005d-a487-491b-9c46-8a5c39705a2b GET /v1/drugs/c1ff005d-a487-491b-9c46-8a5c39705a2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"source": "ndc",
"strength": "665",
"substance": "OLOPATADINE HYDROCHLORIDE",
"productndc": "60505-0845",
"dosage_form": "SPRAY, METERED",
"dea_schedule": null,
"strength_unit": "ug/1",
"application_number": "ANDA091572",
"marketing_category": "ANDA"
}See everything about olopatadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.